Association for Molecular Pathology (AMP) 2021 Molecular Genetic Pathology (MPG) Review Course

Association for Molecular Pathology (AMP) 2021 Molecular Genetic Pathology (MPG) Review Course is organized by Association for Molecular Pathology (AMP) and will be held from May 20 - 23, 2021.

Target Audience:
The AMP 2021 MGP Review Course is especially targeted to pathologists, geneticists, technical laboratory directors, molecular pathology laboratory personnel, and trainees who:
• plan to take a molecular diagnostics certification exam in 2021 or 2022;
• want to obtain the molecular pathology expertise needed in today's pathology practice;
• want to understand regulations that govern the development and use of molecular genetic tests for the safety of patients and research subjects; and/or
• want to gain a basic and/or advanced understanding of diagnostic, prognostic, and therapeutic approaches in the areas of hematopathology (leukemias, lymphomas, lymphoproliferative disorders), solid tumors and soft tissue tumors, infectious diseases (viral, bacterial, fungal, parasitic), and inherited diseases, with the goal of improving patient care and enabling constructive interactions with pathologists, other health care practitioners, and laboratory directors and technologists.

Accreditation:
Physicians:
Amedco LLC designates this live activity for a maximum of 25.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CMLE:
Application has been made in accordance with Amedco and the joint provider-ship of the ASC and the Association for Molecular Pathology (AMP), submitted for 25.50 Credits of CMLE Hours. Please check back for updated information.

Description:
The AMP 2021 MGP Review Course will be designed to meet the participants' education needs in the physician competency area of Medical Knowledge, as defined by the Accreditation Council for Graduate Medical Education (ACGME) and the American Board of Medical Specialties (ABMS), and to support participants' lifelong learning towards a goal of promoting patient safety and improving patient care. At the completion of this activity, participants should be able to discuss the research underway and/or current molecular approaches to the diagnosis and prognosis of inherited diseases (including Bayesian calculations, pharmacogenetics), molecular hematopathology (including clonality, translocations, and point mutations), cytogenetics, solid and soft tissue tumors, and molecular genetic testing of infectious diseases (including bacterial, fungal, viral, and parasitic pathogens) as well as DNA identity.

Topics covered include:
• Molecular Technologies and Lab Methods
• NGS Platforms and Informatics
• Identity Testing
• Inherited Conditions
• Pharmacogenomics
• HLA Transplant Testing
• Cytogenetics
• Molecular Oncology
• Molecular Hematopathology
• Infectious Diseases
• Quality Assurance and Lab Regulation
• Lab Management

Objectives:
The objectives of the AMP 2021 MGP Review Course are:
• To assist attendees in preparing for the MGP Subspecialty Certification Exam (offered jointly by the American Board of Pathology and the American Board of Medical Genetics), as well as other certification exams in molecular pathology and molecular genetics, and
• To increase basic and applied pathology knowledge, focusing on the molecular pathogenesis, diagnosis, prognosis and treatment of disease.